COMPLIMENTARY PRESS REGISTRATION AVAILABLE FOR 2019 STATE-OF-THE-ART CLINICAL SYMPOSIUM


FOR IMMEDIATE RELEASE

February 27, 2019

 

Media Contact

Monica McDonald

mmcdonald@rheumatology.org

404-633-3777 

COMPLIMENTARY PRESS REGISTRATION AVAILABLE FOR 2019 STATE-OF-THE-ART CLINICAL SYMPOSIUM

Newswise — ATLANTA – The American College of Rheumatology (ACR) welcomes members of the press to write about rheumatology research presented at the State-of-the-Art Clinical Symposium (SOTA) in Chicago on April 5-7. This year’s line-up features presentations on challenges in myositis, research findings and scientific advancements for lupus, the latest on stem cell transplant in rheumatic diseases, and more.

Complimentary registration allows eligible press members to attend sessions on-site or to cover sessions remotely. Details about eligibility requirements, how to apply for press credentials, and a program schedule for this year’s meeting is available on the SOTA event page. All journalists interested in attending SOTA should register by Wednesday, March 13.

Anyone with questions about the registration process or press policies & procedures should contact Monica McDonald at mmcdonald@rheumatology.org

###

About the American College of Rheumatology

The American College of Rheumatology is an international medical society representing over 9,400 rheumatologists and rheumatology health professionals with a mission to empower rheumatology professionals to excel in their specialty. In doing so, the ACR offers education, research, advocacy and practice management support to help its members continue their innovative work and provide quality patient care. Rheumatologists are experts in the diagnosis, management and treatment of more than 100 different types of arthritis and rheumatic diseases. For more information, visit www.rheumatology.org.

 

 

  • share-facebook-COMPLIMENTARY PRESS REGISTRATION AVAILABLE FOR 
2019 STATE-OF-THE-ART CLINICAL SYMPOSIUM
  • share-twitter-COMPLIMENTARY PRESS REGISTRATION AVAILABLE FOR 
2019 STATE-OF-THE-ART CLINICAL SYMPOSIUM

Comment/Share

step 2
Chat now!